Dublin, Nov. 06, 2018 (GLOBE NEWSWIRE) -- The "Global Pancreatic Cancer Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

Global Pancreatic Cancer Market and Competitive Landscape - 2018, provides comprehensive insights into Pancreatic Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Pancreatic Cancer market size and drug sales. This research also provides insights into Pancreatic Cancer epidemiology and late stage pipeline.

The research is classified into following sections - Pancreatic Cancer overview with definitions, symptoms, etiology, diagnosis, treatment options; Pancreatic Cancer pipeline insights covering late stage clinical trials pipeline; Pancreatic Cancer prevalence trends by countries; Pancreatic Cancer market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan.

Research Scope:

• Pancreatic Cancer pipeline: Find out the drugs in clinical trials for Pancreatic Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Pancreatic Cancer epidemiology: Find out the prevalence of Pancreatic Cancer by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
• Pancreatic Cancer products: Identify key products marketed and prescribed for Pancreatic Cancer by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
• Pancreatic Cancer market size: Find out the market size for Pancreatic Cancer drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
• Pancreatic Cancer drug sales: Find out the sales of Pancreatic Cancer drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
• Pancreatic Cancer drugs sales forecast: Sales forecast for Pancreatic Cancer drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
• Pancreatic Cancer market share analysis: Find out the market shares of Pancreatic Cancer drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research:

• Evaluate commercial market opportunities for Pancreatic Cancer drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in Pancreatic Cancer market
• Develop in-depth knowledge of competition and markets
• Analyze sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track market trends and analyze key events in Pancreatic Cancer market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1. Pancreatic Cancer: Disease Overview

2. Pancreatic Cancer Pipeline Insights

3. Pancreatic Cancer Epidemiology Analysis

4. US Pancreatic Cancer Market Insights

5. Germany Pancreatic Cancer Market Insights

6. France Pancreatic Cancer Market Insights

7. Italy Pancreatic Cancer Market Insights

8. Spain Pancreatic Cancer Market Insights

9. UK Pancreatic Cancer Market Insights

10. Europe Pancreatic Cancer Market Insights

11. Japan Pancreatic Cancer Market Insights

12. Global Pancreatic Cancer Market Insights

13. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/6ft22w/global_pancreatic?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pancreatic Cancer Drugs